MeiraGTx Holdings (FRA:328) Stock Based Compensation: €17.93 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:328 MeiraGTx Holdings PLC FRA:328
55 GF Score
Price €10.80
GF Value €20.68
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is MeiraGTx Holdings Stock Based Compensation?

MeiraGTx Holdings FRA:328 +0.93% 55 Stock Based Compensation is €17.93 Mil as of Mar. 2026. GuruFocus rates FRA:328 with a GF Score™ of 55/100 and a GF Value™ of €20.68 (Possible Value Trap). The stock has 4 warning signs investors should review.

MeiraGTx Holdings's Stock Based Compensation for the three months ended in Mar. 2026 was €3.16 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was €17.93 Mil.

MeiraGTx Holdings Stock Based Compensation Related Terms

MeiraGTx Holdings Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MeiraGTx Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MeiraGTx Holdings Stock Based Compensation Chart

MeiraGTx Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.39 27.02 25.42 24.06 18.88

MeiraGTx Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.52 4.91 5.07 4.78 3.16
FRA:328
55GF Score
MeiraGTx Holdings PLC FRA:328
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MeiraGTx Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €17.93 Mil.

What does a Stock Based Compensation of €17.93 Mil mean?
MeiraGTx Holdings (FRA:328) has a Stock Based Compensation of €17.93 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MeiraGTx Holdings and its competitors.
Is MeiraGTx Holdings' Stock Based Compensation too high?
MeiraGTx Holdings' current Stock Based Compensation is €17.93 Mil. Overall, MeiraGTx Holdings has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MeiraGTx Holdings' Stock Based Compensation compare to XNCR and WVE?
MeiraGTx Holdings' Stock Based Compensation of €17.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MeiraGTx Holdings and its competitors. MeiraGTx Holdings's current Stock Based Compensation is €17.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeiraGTx Holdings stock overvalued right now?
Based on GuruFocus' analysis, MeiraGTx Holdings (FRA:328) is currently considered Possible Value Trap. The stock's GF Value™ is €20.68, compared to a current price of €10.80 — trading 47.8% below its estimated fair value. The current Stock Based Compensation is €17.93 Mil. MeiraGTx Holdings' overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MeiraGTx Holdings (FRA:328), the current Stock Based Compensation is €17.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MeiraGTx Holdings (FRA:328) Overvalued in 2026?

Based on GuruFocus' analysis, MeiraGTx Holdings stock appears to be undervalued. The current stock price of €10.80 is trading 47.8% below its estimated GF Value™ of €20.68. GuruFocus considers MeiraGTx Holdings to be Possible Value Trap.

Key valuation signals for FRA:328:

  • Stock Based Compensation: €17.93 Mil
  • GF Value™: €20.68 vs. price of €10.80 (47.8% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the FRA:328 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MeiraGTx Holdings Business Description

Other Exchanges MGTX:USA328:Germany
Address 655 Third Avenue, Suite 1115, New York, NY, USA, 10017
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
55GF Score

Get the complete analysis for FRA:328

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€20.68
GF Value